After the market close on Thursday, the healthcare workforce solutions company reported adjusted earnings of 47 cents per share, compared to analysts' forecasts for earnings of 41 cents per share.
Revenue jumped by 44% year-over-year to $402.6 million, beating analysts' estimates for revenue of $387.61 million.
Additionally, AMN projected 2016 first quarter revenue to range between $444 million to $450 million, well above Wall Street's projections for revenue of $394.13 million.
"Our team delivered industry-leading revenue and earnings growth, and we exceeded our previously stated objective of a 10% adjusted EBITDA margin," CEO Susan Salka said in a statement. "Our shareholders also benefitted with a total shareholder return of 58% for 2015."
Separately, recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
TheStreet Ratings rates this stock as a "buy" with a ratings score of B. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins.
You can view the full analysis from the report here: AHSAHS data by YCharts